Logo image of AH.CA

Aleafia Health Inc (AH.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:AH - CA01444Q1046 - Common Stock

0.02 CAD
0 (0%)
Last: 7/25/2023, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, AH scores 2 out of 10 in our fundamental rating. AH was compared to 32 industry peers in the Pharmaceuticals industry. AH has a bad profitability rating. Also its financial health evaluation is rather negative. AH shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AH had negative earnings in the past year.
In the past year AH has reported a negative cash flow from operations.
In the past 5 years AH always reported negative net income.
In the past 5 years AH always reported negative operating cash flow.
AH.CA Yearly Net Income VS EBIT VS OCF VS FCFAH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

The profitability ratios for AH are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AH.CA Yearly ROA, ROE, ROICAH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

AH has a Gross Margin (21.35%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AH has declined.
The Profit Margin and Operating Margin are not available for AH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-52.06%
GM growth 5Y-25.49%
AH.CA Yearly Profit, Operating, Gross MarginsAH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

AH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AH has been increased compared to 1 year ago.
AH has more shares outstanding than it did 5 years ago.
AH has a worse debt/assets ratio than last year.
AH.CA Yearly Shares OutstandingAH.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
AH.CA Yearly Total Debt VS Total AssetsAH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

AH has an Altman-Z score of -12.50. This is a bad value and indicates that AH is not financially healthy and even has some risk of bankruptcy.
AH's Altman-Z score of -12.50 is on the low side compared to the rest of the industry. AH is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.5
ROIC/WACCN/A
WACC4.33%
AH.CA Yearly LT Debt VS Equity VS FCFAH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

AH has a Current Ratio of 0.83. This is a bad value and indicates that AH is not financially healthy enough and could expect problems in meeting its short term obligations.
AH has a worse Current ratio (0.83) than 74.42% of its industry peers.
A Quick Ratio of 0.22 indicates that AH may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, AH is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.22
AH.CA Yearly Current Assets VS Current LiabilitesAH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

AH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.40%, which is quite impressive.
The Revenue has grown by 52.19% in the past year. This is a very strong growth!
AH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.75% yearly.
EPS 1Y (TTM)79.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.84%
Revenue 1Y (TTM)52.19%
Revenue growth 3Y37.87%
Revenue growth 5Y61.75%
Sales Q2Q%33.46%

3.2 Future

Based on estimates for the next years, AH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.32% on average per year.
AH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.85% yearly.
EPS Next Y40%
EPS Next 2Y18.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year51.58%
Revenue Next 2Y31.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AH.CA Yearly Revenue VS EstimatesAH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AH.CA Yearly EPS VS EstimatesAH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AH.CA Price Earnings VS Forward Price EarningsAH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AH.CA Per share dataAH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

A more expensive valuation may be justified as AH's earnings are expected to grow with 18.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Aleafia Health Inc

TSX:AH (7/25/2023, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.06%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.06M
Revenue(TTM)54.88M
Net Income(TTM)-39.08M
Analysts40
Price Target0.15 (650%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.41%
Min Revenue beat(2)-38.79%
Max Revenue beat(2)-20.04%
Revenue beat(4)1
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-38.79%
Max Revenue beat(4)92.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.14
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-52.06%
GM growth 5Y-25.49%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.19%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.22
Altman-Z -12.5
F-Score4
WACC4.33%
ROIC/WACCN/A
Cap/Depr(3y)79.73%
Cap/Depr(5y)248.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.84%
EPS Next Y40%
EPS Next 2Y18.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.19%
Revenue growth 3Y37.87%
Revenue growth 5Y61.75%
Sales Q2Q%33.46%
Revenue Next Year51.58%
Revenue Next 2Y31.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.35%
OCF growth 3YN/A
OCF growth 5YN/A

Aleafia Health Inc / AH.CA FAQ

What is the ChartMill fundamental rating of Aleafia Health Inc (AH.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AH.CA.


Can you provide the valuation status for Aleafia Health Inc?

ChartMill assigns a valuation rating of 0 / 10 to Aleafia Health Inc (AH.CA). This can be considered as Overvalued.


How profitable is Aleafia Health Inc (AH.CA) stock?

Aleafia Health Inc (AH.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for AH stock?

The financial health rating of Aleafia Health Inc (AH.CA) is 0 / 10.


Can you provide the expected EPS growth for AH stock?

The Earnings per Share (EPS) of Aleafia Health Inc (AH.CA) is expected to grow by 40% in the next year.